China Biotech Services Holdings Limited (SEHK: 8037)
Health Care · Health Care Providers & Services · HK
HK$0.51
-12.93% today · -49.0% 1Y
China Biotech Services Holdings Limited (SEHK: 8037) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $62.79M and employs 166 people.
Over the last twelve months the share price has lost 49.0%, trading between 0.30 and 1.04.
Tweenvest scores China Biotech Services Holdings Limited across four factors: quality 42/100, value 72/100, growth 0/100. Its strongest factor is value.
8037 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $62.79M
- Revenue (TTM)
- $10.95M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -0.69
- 52-week high
- HK$1.04
- 52-week low
- HK$0.30
- Avg volume (3M)
- —
- Shares outstanding
- 975.73M
- Employees
- 166
- Next earnings
- —
About China Biotech Services Holdings Limited
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
- ISIN
- BMG2152F1014
- Founded
- 1996
- Listed since
- Jun 17, 2004
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EQL Pharma AB (publ)OM: EQL | $65.56M | Skr22.80 | +2.70% |
| Kato (Hong Kong) Holdings LimitedSEHK: 2189 | $63.71M | HK$0.50 | +4.17% |
| Ma Kuang Healthcare Holding LimitedTPEX: 4139 | $63.34M | NT$45.00 | +7.27% |
| MedPal AI PLCAIM: MPAL | $63.22M | £0.06 | -0.82% |
| CM Hospitalar S/ABOVESPA: VVEO3 | $61.49M | R$0.97 | +19.75% |
| FamiCord AGXTRA: V3V | $59.73M | €2.95 | -3.59% |
| Chandan Healthcare LimitedNSEI: CHANDAN | $59.37M | Rs235.00 | +3.48% |
| Nakornthon Hospital Public Company LimitedSET: NKT | $59.00M | ฿3.70 | +0.54% |
Figures last refreshed Oct 11, 2026.